Approval · Notice of Compliance 3147 · 1998
RISPERDAL: Notice of Compliance 3147
Issued April 17, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3147
- Date
- April 17, 1998
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antipsychotic agent
Products in this notice
Medicinal ingredients
- RISPERIDONE 1 MG per TAB
- RISPERIDONE 2 MG per TAB
- RISPERIDONE 3 MG per TAB
- RISPERIDONE 4 MG per TAB
- RISPERIDONE 5 MG per TAB
- RISPERIDONE 1 MG per ML